As of Feb 10
| +0.14 / +0.39%|
The 5 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 72.00, with a high estimate of 83.00 and a low estimate of 62.00. The median estimate represents a +97.37% increase from the last price of 36.48.
The current consensus among 5 polled investment analysts is to Hold stock in Agios Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.